Johnson & Johnson COVID-19 vaccine update

On Tuesday, April 13, the CDC and FDA recommended temporarily pausing further administration of the Johnson & Johnson vaccine out of an abundance of extreme caution.

The Bloomington Public Health Division is following recommendations from the Centers for Disease Control and Prevention, Food and Drug Administration, and the State of Minnesota to temporarily pause use of the J&J vaccine at this time. Additionally, no state vaccination sites are using the J&J vaccine this week.

The recommendation comes after 6 people out of almost 7 million who have received the J&J vaccine experienced a rare and severe type of blood clot after getting their shot. All 6 cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.

The CDC’s Advisory Committee on Immunization Practices will meet Wednesday, April 14, to further review these cases and assess their potential significance. The FDA will also review that analysis and investigate the cases on its own.

While these incidents have been extremely rare, anyone who has received the J&J vaccine who develops severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

For any questions or concerns, please contact your health care provider or visit